Evidence map›Paper›PMID 23602451›Full record

ArticleMolecular immunology2013

Stereo-selective binding of monoclonal antibodies to the poly-γ-D-glutamic acid capsular antigen of Bacillus anthracis.

Mark A Hubbard, Peter Thorkildson, William H Welch, Thomas R Kozel

Abstract read
In one paragraph

Article in Molecular immunology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Mark A HubbardDepartment of Microbiology and Immunology, University of Nevada School of Medicine, Reno, NV 89557, USA.
Peter Thorkildson
William H Welch
Thomas R Kozel

Funding

B. anthracis:passive immunization with anticapsular mAbR01AI059348 · NIAID · UNIVERSITY OF NEVADA RENO · PI KOZEL, THOMAS R · 2004 to 2012
$3.5M
Immunoassay for capsular antigen for rapid diagnosis of anthraxR01AI093365 · NIAID · UNIVERSITY OF NEVADA RENO · PI KOZEL, THOMAS R · 2011 to 2015
$3.4M
PGA antigenemia for early diagnosis of anthraxU01AI061200 · NIAID · UNIVERSITY OF NEVADA RENO · PI KOZEL, THOMAS R · 2005 to 2009
$3.3M
NIAID NIH HHS R01 AI059348NIAID NIH HHS R01AI059348NIAID NIH HHS R01 AI093365NIAID NIH HHS R01AI093365NIAID NIH HHS U01 AI061200
6 · The paper itself

Abstract

Bacillus anthracis is surrounded by an anti-phagocytic capsule that is entirely composed of γ-linked D-glutamic acid (γDPGA). γDPGA is required for virulence and is produced in large quantities following spore germination. We have previously described the isolation of several γDPGA-reactive mAbs. The reagents are effective in both immunoprotection and diagnostic applications. The current work was done to further investigate the specificity of γDPGA-reactive mAbs. The specificity of each mAb was characterized using surface plasmon resonance. Our results indicate that each mAb is stereoselective for binding to D-glutamic acid oligomers, but to varying degrees. In particular, mAb F26G3 is highly selective for γDPGA; alterations in stereochemistry disrupted recognition. These differences in mAb reactivity suggest that binding of γDPGA by mAb F26G3 is more specific than non-directional ionic interactions between a negatively charged antigen and a positively charged antibody.

Indexed as

Antibody AffinityAnimalsAntibodies, MonoclonalAntibody SpecificityAntigen-Antibody ReactionsAntigens, BacterialBacillus anthracisBacterial CapsulesMiceModels, ImmunologicalPolyglutamic AcidStereoisomerismAntibodies, MonoclonalAntigens, Bacterialpoly(gamma-glutamic acid)Polyglutamic Acid

Identifiers

PMID23602451
PMCPMC3783358

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.